Imperva Inc. (NYSE:IMPV) insider Amichai Shulman sold 3,085 shares of Imperva stock in a transaction on Tuesday, November 15th. The shares were sold at an average price of $40.10, for a total value of $123,708.50. Following the transaction, the insider now owns 92,000 shares of the company’s stock, valued at approximately $3,689,200. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.

Amichai Shulman also recently made the following trade(s):

  • On Monday, October 17th, Amichai Shulman sold 3,085 shares of Imperva stock. The shares were sold at an average price of $48.57, for a total value of $149,838.45.
  • On Monday, October 3rd, Amichai Shulman sold 938 shares of Imperva stock. The shares were sold at an average price of $53.27, for a total value of $49,967.26.
  • On Friday, September 23rd, Amichai Shulman sold 937 shares of Imperva stock. The shares were sold at an average price of $51.00, for a total value of $47,787.00.
  • On Thursday, September 15th, Amichai Shulman sold 3,085 shares of Imperva stock. The shares were sold at an average price of $44.30, for a total value of $136,665.50.

Imperva Inc. (NYSE:IMPV) opened at 39.45 on Friday. The stock has a 50 day moving average price of $43.22 and a 200-day moving average price of $43.23. Imperva Inc. has a 1-year low of $31.11 and a 1-year high of $77.99. The company’s market cap is $1.30 billion.

Imperva (NYSE:IMPV) last issued its earnings results on Thursday, November 3rd. The company reported $0.08 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of ($0.16) by $0.24. The company earned $68.40 million during the quarter, compared to analyst estimates of $63.10 million. Imperva had a negative return on equity of 28.37% and a negative net margin of 25.60%. The firm’s quarterly revenue was up 8.0% on a year-over-year basis. During the same quarter last year, the business posted $0.19 EPS. On average, equities research analysts forecast that Imperva Inc. will post ($0.39) EPS for the current year.

Insider Buying and Selling by Quarter for Imperva (NYSE:IMPV)

A number of brokerages have issued reports on IMPV. DA Davidson cut Imperva from a “buy” rating to a “neutral” rating and set a $55.00 price objective for the company. in a research note on Thursday, October 6th. They noted that the move was a valuation call. BTIG Research cut Imperva from a “buy” rating to a “neutral” rating in a research note on Monday, October 3rd. Buckingham Research cut Imperva from a “buy” rating to a “neutral” rating in a research note on Thursday, September 29th. Nomura cut Imperva from a “buy” rating to a “neutral” rating and set a $50.00 price target for the company. in a research note on Monday, September 26th. Finally, JMP Securities restated an “outperform” rating and issued a $56.00 price target (up previously from $50.00) on shares of Imperva in a research note on Sunday, September 25th. One analyst has rated the stock with a sell rating, six have given a hold rating, fourteen have given a buy rating and one has given a strong buy rating to the stock. The company currently has a consensus rating of “Buy” and an average price target of $49.69.

Institutional investors have recently modified their holdings of the company. Credit Suisse AG raised its position in Imperva by 865.9% in the second quarter. Credit Suisse AG now owns 1,431,447 shares of the company’s stock worth $61,568,000 after buying an additional 1,283,243 shares during the last quarter. Litespeed Management L.L.C. raised its position in Imperva by 893.6% in the third quarter. Litespeed Management L.L.C. now owns 943,915 shares of the company’s stock worth $50,698,000 after buying an additional 848,915 shares during the last quarter. Pictet Asset Management Ltd. raised its position in Imperva by 50.6% in the second quarter. Pictet Asset Management Ltd. now owns 804,552 shares of the company’s stock worth $30,718,000 after buying an additional 270,312 shares during the last quarter. FIL Ltd bought a new position in Imperva during the second quarter worth $10,170,000. Finally, Jet Capital Investors L P bought a new position in Imperva during the second quarter worth $9,670,000. Institutional investors own 87.53% of the company’s stock.

About Imperva

Imperva, Inc provides cyber-security solutions that protect business-critical data and applications whether in the cloud or on premises. The Company operates in the segment of development, marketing, sales, service and support of cyber-security solutions that protect business critical data and applications whether in the cloud or on premises.

5 Day Chart for NYSE:IMPV

Receive News & Stock Ratings for Imperva Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Imperva Inc. and related stocks with our FREE daily email newsletter.